Nyxoah SA (NYXH)
Nasdaq · Healthcare · Medical Devices
$1.41+3.68%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $144M
- 52-week range
- $1.26 – $6.88
- 52-week change
- −79.14%
- EPS (trailing)
- −$2.56
- Next earnings
- Nov 5, 2026
About Nyxoah SA
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Headquarters: Mont-Saint-Guibert, Belgium · 153 employees · nyxoah.com